Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.

Kragsnaes MS, Gilbert BTP, Sofíudóttir BK, Rooney CM, Hansen SM, Mauro D, Mullish BH, Bergot AS, Mankia KS, Goel N, Bakland G, Johnsen PH, Miguens Blanco J, Li S, Dumas E, Lage-Hansen PR, Wagenaar C, Bakdash G, Robinson M, Kristiansen K, Marchesi JR, Schett G, Zaiss MM, Orlu M, van Schaadenburg D, Scher JU, McGonagle D, Elewaut D, Breban M, Tugwell P, Finckh A, Ciccia F, Kriegel MA, Daien C, Ellingsen T, Christensen R, EULAR Study Group MICMUC.

Open source

DOI: 10.1136/bmjopen-2025-101593
Published: 2025-12-14
Container: BMJ Open
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2025-101593,
  title = {Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.},
  author = {Kragsnaes MS and  Gilbert BTP and  Sofíudóttir BK and  Rooney CM and  Hansen SM and  Mauro D and  Mullish BH and  Bergot AS and  Mankia KS and  Goel N and  Bakland G and  Johnsen PH and  Miguens Blanco J and  Li S and  Dumas E and  Lage-Hansen PR and  Wagenaar C and  Bakdash G and  Robinson M and  Kristiansen K and  Marchesi JR and  Schett G and  Zaiss MM and  Orlu M and  van Schaadenburg D and  Scher JU and  McGonagle D and  Elewaut D and  Breban M and  Tugwell P and  Finckh A and  Ciccia F and  Kriegel MA and  Daien C and  Ellingsen T and  Christensen R and  EULAR Study Group MICMUC.},
  year = {2025},
  journal = {BMJ Open},
  doi = {10.1136/bmjopen-2025-101593},
  url = {https://doi.org/10.1136/bmjopen-2025-101593}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.
AU  - Kragsnaes MS
AU  -  Gilbert BTP
AU  -  Sofíudóttir BK
AU  -  Rooney CM
AU  -  Hansen SM
AU  -  Mauro D
AU  -  Mullish BH
AU  -  Bergot AS
AU  -  Mankia KS
AU  -  Goel N
AU  -  Bakland G
AU  -  Johnsen PH
AU  -  Miguens Blanco J
AU  -  Li S
AU  -  Dumas E
AU  -  Lage-Hansen PR
AU  -  Wagenaar C
AU  -  Bakdash G
AU  -  Robinson M
AU  -  Kristiansen K
AU  -  Marchesi JR
AU  -  Schett G
AU  -  Zaiss MM
AU  -  Orlu M
AU  -  van Schaadenburg D
AU  -  Scher JU
AU  -  McGonagle D
AU  -  Elewaut D
AU  -  Breban M
AU  -  Tugwell P
AU  -  Finckh A
AU  -  Ciccia F
AU  -  Kriegel MA
AU  -  Daien C
AU  -  Ellingsen T
AU  -  Christensen R
AU  -  EULAR Study Group MICMUC.
PY  - 2025
JO  - BMJ Open
DO  - 10.1136/bmjopen-2025-101593
UR  - https://doi.org/10.1136/bmjopen-2025-101593
ER  -

APA

MS, K., BTP, G., BK, S., CM, R., SM, H., D, M., BH, M., AS, B., KS, M., N, G., G, B., PH, J., J, M. B., S, L., E, D., PR, L., C, W., G, B., M, R., K, K., JR, M., G, S., MM, Z., M, O., D, V. S., JU, S., D, M., D, E., M, B., P, T., A, F., F, C., MA, K., C, D., T, E., R, C., & MICMUC., E. S. G. (2025). Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.. BMJ Open. https://doi.org/10.1136/bmjopen-2025-101593

Source records

europe-pmc · retrieved 2026-09-26T07:08:16.410Z
doaj · retrieved 2026-09-26T07:08:16.436Z